Raymond James Financial Services Advisors’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-8,550
| Closed | -$1.47M | – | 3406 |
|
|
2021
Q3 | $1.47M | Buy |
8,550
+1,876
| +28% | +$323K | ﹤0.01% | 1688 |
|
|
2021
Q2 | $838K | Buy |
6,674
+1,279
| +24% | +$161K | ﹤0.01% | 2061 |
|
|
2021
Q1 | $732K | Buy |
+5,395
| New | +$732K | ﹤0.01% | 2058 |
|
|
2019
Q1 | – | Sell |
-5,111
| Closed | -$223K | – | 2843 |
|
|
2018
Q4 | $223K | Buy |
+5,111
| New | +$223K | ﹤0.01% | 2187 |
|